Z-521 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
238	Vitamin D-resistant rickets	2

238. Vitamin D-resistant rickets

Clinical trials : 29 / Drugs : 25 - (DrugBank : 11) / Drug target genes : 4 - Drug target pathways : 20

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-101332	01/9/2010	02/11/2010	Therapeutic use of Z-521	Therapeutic use of oral sodium phosphate (Z-521) in primary hypophosphatemic rickets (familial ricke ...	primary hypophosphatemic rickets	Intervention name : Z-521 Dosage And administration of the intervention : 300-3000mg inorganic phosph ...	Zeria Pharmaceutical Co., Ltd.	NULL		1	14	BOTH	10	Phase 3	NULL
2	NCT01237288 (ClinicalTrials.gov)	September 2010	7/11/2010	Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets	Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets	Primary Hypophosphatemic Rickets	Drug: Z-521	Zeria Pharmaceutical	NULL	Completed	1 Year	14 Years	Both	16	Phase 3	Japan

First Previous1Next Last